R. Schwarzhoff et al., SPECIFIC MONOCLONAL-ANTIBODIES NEUTRALIZE THE ACTION OF PACAP-1-27 ORPACAP-1-38 ON INTESTINAL MUSCLE STRIPS IN-VITRO, Regulatory peptides, 55(1), 1995, pp. 57-66
The gut-brain neuropeptide pituitary adenylate cyclase activating poly
peptide (PACAP) is a novel highly conserved member of the secretin-glu
cagon-VIP peptide family comprising 38 or 27 amino acid residues. In t
his study, we investigate the actions of PACAP 1-27 or PACAP 1-38 on j
ejunal and caecal muscle strips from pig or guinea pig and demonstrate
the neutralizing effect of two PACAP-specific monoclonal antibodies o
f the IgG, subtype, RSP27II and RSP38. These antibodies were used to s
et up assay systems specific for PACAP 1-27 or PACAP 1-38. Monoclonal
antibody RSP27II recognizes exclusively PACAP 1-27, whereas RSP38 bind
s only PACAP 1-38. PACAP 1-27 and PACAP 1-38 relax taenia caeci dose-d
ependently in the presence of guanethidine and scopolamine. Both pepti
des inhibit the spontaneous contractions of porcine jejunal muscle str
ips equipotently. Monoclonal antibodies RSP27II and RSP38 specifically
neutralize the actions of either exogenously applied or endogenously
released PACAP. Thus, they represent processing-specific tools to exam
ine the physiological role of both molecular forms of PACAP in the gas
trointestinal tract.